Dirk Arnold, MD, PhD

home / authors / dirk-arnold-md-phd

Medical director, Asklepios Tumour Biology Centre

Articles

June 10th 2025

Exploring Amivantamab's Potential in Colorectal Cancer: Dirk Arnold, MD, PhD

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses the trial design of a study comparing amivantamab with standard chemotherapy to potentially improve treatment outcomes.

June 4th 2025

Why ASCO Is a Must-Attend Event for Oncologists Worldwide

Pearl Steinzor Dirk Arnold, MD, PhD Vincent Picozzi, MD Danny Rischin, MD

Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.

June 2nd 2025

Amivantamab Trial Promises New Hope for Colorectal Cancer Treatment: Dirk Arnold, MD, PhD

Pearl Steinzor Dirk Arnold, MD, PhD

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses a phase 3 clinical trial investigating amivantamab in metastatic colorectal cancer.